News

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that its

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence

Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Jefferies Virtual Healthcare Conference on June 1. Details are included below:

Jefferies Virtual Healthcare

Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a

Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 19.4 cents per share of common stock will be paid on July 28, 2021, to all shareholders of record as of the close

Waters Corporation founder James L. Waters, a legendary inventor and pioneer in liquid chromatography whose work spurred a multi-billion-dollar industry and helped advance numerous scientific

Susan Salka, President and CEO of AMN Healthcare (NYSE: AMN), has been named to the inaugural list of Diversity, Equality and Inclusion (DE&I) Influencers by Staffing Industry Analysts.

This press

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing share repurchase program

Humana Inc. (NYSE: HUM) today unveiled its 2021 Bold Goal Progress Report, which details the company’s progress with its ambitious population health strategy launched in 2015 to improve the health

Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2021 annual stockholders’ meeting. Each of the directors continues from the prior term.

Illumina, Inc. (NASDAQ: ILMN) today announced that it is appointing Susan Tousi as Chief Commercial Officer (CCO), and Dr. Alex Aravanis as Chief Technology Officer (CTO), Head of Research and

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that its

Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that

Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021, at approximately 10:20

Physicians completing their training are getting fewer recruiting offers than in the past, most likely due to Covid-19, a new survey suggests. The survey also indicates that female physicians

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that members of its management team will participate in presentations

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2021 financial

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first

Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), today announces a new partnership with No Kid Hungry, a national campaign dedicated

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today a retail

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the first quarter ended March 31, 2021